Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02119702 · ClinicalTrials.gov registry record
Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)
A clinical trial, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- 818
- Enrollment target
NCT02119702: Completed study, sponsored by Harvard School of Public Health (HSPH).
NCT02119702 is a clinical trial that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 818 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02119702 has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- 818 participants
- Enrollment target
Study Summary
This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection (YAPHIV) as they transition into adulthood. A group of of perinatally exposed but uninfected young adults from a similar sociodemographic background and age distribution will be enrolled for comparison.
Primary Outcome
Factors of interest for this outcome include virologic suppression, immune impairment, immune activation, changes in ART, cumulative exposure to specific ART, viral resistance, co-infections, and host genetic polymorphisms. Data will be collected through chart abstraction and laboratory assessments and central laboratory testing.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 818 participants |
| Start Date | 2014-04 |
| Est. Completion | 2025-05-31 |
What the finished NCT02119702 record still lists
NCT02119702 is an observational study that tracks outcomes without assigning an intervention. The registered 818 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02119702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02119702 about?
NCT02119702 is a clinical study titled "Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)". This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection (YAPHIV) as they transition into adulthood. A group of of perinatally exposed but uninfected young adults from a similar sociodemographic ba...
What is the current status of trial NCT02119702?
This trial is currently completed. The enrollment target is 818 participants. The study started on 2014-04. Estimated completion is 2025-05-31.
Who is sponsoring clinical trial NCT02119702?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04846959 · 818 participants
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- NCT04028687 · 820 participants
MDR - PMCF Study for Taperloc Complete Stems
- NCT04613440 · 820 participants · NA
FaCT Trial (Facilitated Cascade Testing Trial)
- NCT04910269 · 820 participants · Phase 3
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia